Worth reading
51Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Mixed performance
Direction inferred from the company’s description.Scale
2113
¥ million (year-on-year increase in revenue)Wording
Conditional
How definitive the wording is.Contents of this document
Supplementary materials to the earnings reportFirst quarter of the fiscal year ending March 202710 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥41,420 million+5.4%
Operating profit¥3,359 million-2.9%
Ordinary income¥3,438 million-4.6%
Net income¥2,541 million+3.7%
Operating profit margin8.1% (down 1.0 percentage point year on year. In the earnings overview table, the operating margin was 8.8% in the prior-year period and 8.1% in the current period.)
Results for the three months of the current quarterNet sales of ¥41.4 billion, operating income of ¥3.3 billion, ordinary income of ¥3.4 billion, and net income attributable to owners of the parent of ¥2.5 billion. Standalone quarterly results for each business are also presented.
Full-year earnings forecast
Net Sales
¥176,000 million
Operating profit
¥11,200 million
Ordinary income
¥11,500 million
Profit attributable to owners of the parent
¥6,500 million
What the company explained in this material
Breakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
Operating income declined by ¥400 million in Wellness, increased by ¥400 million in Environmental Solutions, increased by ¥100 million in Information Electronics, and declined by ¥100 million in Industrial Infrastructure. The bridge showing the factors by amount is not disclosed.
Assumptions Underlying the Business OutlookThe assumptions used by the company in preparing its forecast.
Qualitative assumptions include demand trends, continued strength in the semiconductor market, passing on higher prices, production adjustments, operation of the extra-wide-width machine, and higher fixed costs. Numerical assumptions are not disclosed.New initiatives
- Resource allocation focused on promising areas in the biotechnology-related business
- Expanding production capacity and stabilizing quality through the start of operations at a new building at the Kanto Plant
Key KPIsA metric the company considers important as a management benchmark.
- Earnings per share¥35.51
- Book value per share¥1,343.6
- Equity ratio60.2 ％
- PBR
- ROA
- ROIC
- ROE
Segment results
Wellness
Net Sales
65 Hundreds of millions of yen-10.0%
Operating profit
-1 Hundreds of millions of yen
Environmental Solutions
Net Sales
90 Hundreds of millions of yen+9.7%
Operating profit
8 Hundreds of millions of yen+90.6%
Information and Electronics
Net Sales
152 Hundreds of millions of yen+11.3%
Operating profit
14 Hundreds of millions of yen+8.0%
Industrial Infrastructure
Net Sales
105 Hundreds of millions of yen+4.9%
Operating profit
11 Hundreds of millions of yen-14.8%
Financial targets
Historical trends in financial metrics are presented, but target figures are not disclosed.Capital expenditures
1,524 Millions of yen first-quarter results) / ¥15,979 million (full-year forecast
Annual Dividend
Annual dividend per share¥36
Payout ratio
43.9% (total payout ratio expected for fiscal 2026)Acquisition of treasury shares
Acquisition amount¥276 million
| Item | Details |
|---|---|
| Document type | Supplementary materials to the earnings report |
| Fiscal Period Covered | First quarter of the fiscal year ending March 2027 |
| Net Sales | ¥41,420 million (YoY +5.4%) |
| Operating profit | ¥3,359 million (YoY -2.9%) |
| Ordinary income | ¥3,438 million (YoY -4.6%) |
| Net income | ¥2,541 million (YoY +3.7%) |
| Operating profit margin | 8.1% (down 1.0 percentage point year on year. In the earnings overview table, the operating margin was 8.8% in the prior-year period and 8.1% in the current period.) |
| Results for the three months of the current quarter | Net sales of ¥41.4 billion, operating income of ¥3.3 billion, ordinary income of ¥3.4 billion, and net income attributable to owners of the parent of ¥2.5 billion. Standalone quarterly results for each business are also presented. |
| Full-year earnings forecast | Net Sales ¥176,000 million / Operating profit ¥11,200 million / Ordinary income ¥11,500 million / Profit attributable to owners of the parent ¥6,500 million |
| Segment results | Wellness Net Sales 65 Hundreds of millions of yen (YoY -10.0%) / Operating profit -1 Hundreds of millions of yen / Environmental Solutions Net Sales 90 Hundreds of millions of yen (YoY +9.7%) / Operating profit 8 Hundreds of millions of yen (YoY +90.6%) / Information and Electronics Net Sales 152 Hundreds of millions of yen (YoY +11.3%) / Operating profit 14 Hundreds of millions of yen (YoY +8.0%) / Industrial Infrastructure Net Sales 105 Hundreds of millions of yen (YoY +4.9%) / Operating profit 11 Hundreds of millions of yen (YoY -14.8%) |
| Breakdown of Factors Affecting the Change | Operating income declined by ¥400 million in Wellness, increased by ¥400 million in Environmental Solutions, increased by ¥100 million in Information Electronics, and declined by ¥100 million in Industrial Infrastructure. The bridge showing the factors by amount is not disclosed. |
| Key KPIs | Indicator name Earnings per share / Value ¥35.51 / Year on year against the same period last year Not disclosed, Indicator name Book value per share / Value ¥1,343.6 / Year on year against the same period last year Not disclosed, Indicator name Equity ratio / Value 60.2 ％ / Year on year against the same period last year Not disclosed, Indicator name PBR / Value Not disclosed / Year on year against the same period last year Not disclosed, Indicator name ROA / Value Not disclosed / Year on year against the same period last year Not disclosed, Indicator name ROIC / Value Not disclosed / Year on year against the same period last year Not disclosed, Indicator name ROE / Value Not disclosed / Year on year against the same period last year Not disclosed |
| Assumptions Underlying the Business Outlook | Qualitative assumptions include demand trends, continued strength in the semiconductor market, passing on higher prices, production adjustments, operation of the extra-wide-width machine, and higher fixed costs. Numerical assumptions are not disclosed. |
| Financial targets | Historical trends in financial metrics are presented, but target figures are not disclosed. |
| Annual Dividend | Annual dividend per share ¥36 / Interim Not disclosed / End of period Not disclosed |
| Payout ratio | 43.9% (total payout ratio expected for fiscal 2026) |
| Acquisition of treasury shares | Acquisition amount ¥276 million / Number of Shares Not disclosed / Period Not disclosed |
| Capital expenditures | 1,524 Millions of yen (first-quarter results) / ¥15,979 million (full-year forecast) |
| New initiatives | Resource allocation focused on promising areas in the biotechnology-related business, Expanding production capacity and stabilizing quality through the start of operations at a new building at the Kanto Plant |
Items this document does not state (12)
Gross Profit MarginSelling, general and administrative expensesProgress against full-year forecastSelf-assessment against the planUnit price and quantity metricsNumber of stores and locationsNumber of employeesRisk amount incorporated into the outlookMedium-term management plan targetsOrders received and order backlogMarket Size / ShareKey points of the Q&A
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.In the Wellness business, supply disruptions caused by quality issues with raw materials and temporary fluctuations in demand from major biotechnology-related customers were factors behind the declines in net sales and operating income. The company explained that the main factors were the positive effect of higher sales in the Environmental Solutions business, higher sales of interlayer insulating film in the Information Electronics business due to growth in the semiconductor market for AI applications, and changes in the product mix and higher fixed costs in the Industrial Infrastructure business.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.